| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976758 | Brachytherapy | 2012 | 6 Pages |
Abstract
Excellent disease control outcomes can be achieved after either RP or BT as monotherapy for men with early stage prostate cancer. Upgrading of GS from 6 to 7, either (3Â +Â 4) or (4Â +Â 3), did not predict for worse outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Christine M. Fisher, Patricia Troncoso, David A. Swanson, Mark F. Munsell, Deborah A. Kuban, Andrew K. Lee, Shih-Fan Yeh, Steven J. Frank,